These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18196745)

  • 101. Cloning, Prokaryotic Soluble Expression, and Analysis of Antiviral Activity of Two Novel Feline IFN-ω Proteins.
    Wang X; Li F; Han M; Jia S; Wang L; Qiao X; Jiang Y; Cui W; Tang L; Li Y; Xu YG
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32204464
    [TBL] [Abstract][Full Text] [Related]  

  • 102.
    Setthawongsin C; Tangkawattana S; Rungsipipat A; Techangamsuwan S
    Front Vet Sci; 2019; 6():104. PubMed ID: 31024941
    [No Abstract]   [Full Text] [Related]  

  • 103. Targeting a newly established spontaneous feline fibrosarcoma cell line by gene transfer.
    Nande R; Di Benedetto A; Aimola P; De Carlo F; Carper M; Claudio CD; Denvir J; Valluri J; Duncan GC; Claudio PP
    PLoS One; 2012; 7(5):e37743. PubMed ID: 22666387
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The Use of Recombinant Feline Interferon Omega Therapy as an Immune-Modulator in Cats Naturally Infected with Feline Immunodeficiency Virus: New Perspectives.
    Leal RO; Gil S
    Vet Sci; 2016 Oct; 3(4):. PubMed ID: 29056740
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Interferon-omega: Current status in clinical applications.
    Li SF; Zhao FR; Shao JJ; Xie YL; Chang HY; Zhang YG
    Int Immunopharmacol; 2017 Nov; 52():253-260. PubMed ID: 28957693
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega.
    Hampel V; Schwarz B; Kempf C; Köstlin R; Schillinger U; Küchenhoff H; Fenske N; Brill T; Hirschberger J
    J Vet Intern Med; 2007; 21(6):1340-6. PubMed ID: 18196745
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Limited efficacy of topical recombinant feline interferon-omega for treatment of cats with acute upper respiratory viral disease.
    Ballin AC; Schulz B; Helps C; Sauter-Louis C; Mueller RS; Hartmann K
    Vet J; 2014 Dec; 202(3):466-70. PubMed ID: 25457261
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Evaluation of the efficacy of the subcutaneous low recombinant feline interferon-omega administration protocol for feline chronic gingivitis-stomatitis in feline calicivirus-positive cats.
    Matsumoto H; Teshima T; Iizuka Y; Sakusabe A; Takahashi D; Amimoto A; Koyama H
    Res Vet Sci; 2018 Dec; 121():53-58. PubMed ID: 30359811
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation.
    Gil S; Leal RO; McGahie D; Sepúlveda N; Duarte A; Niza MM; Tavares L
    Res Vet Sci; 2014 Feb; 96(1):79-85. PubMed ID: 24332273
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats.
    de Mari K; Maynard L; Sanquer A; Lebreux B; Eun HM
    J Vet Intern Med; 2004; 18(4):477-82. PubMed ID: 15320583
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours.
    Penzo C; Ross M; Muirhead R; Else R; Argyle DJ
    Vet Comp Oncol; 2009 Dec; 7(4):222-9. PubMed ID: 19891692
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Veterinary Co-operative Oncology Group - Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0.
    Veterinary Co-operative Oncology Group (VCOG)
    Vet Comp Oncol; 2004 Dec; 2(4):195-213. PubMed ID: 19379294
    [No Abstract]   [Full Text] [Related]  

  • 113. Clonal origin and evolution of a transmissible cancer.
    Murgia C; Pritchard JK; Kim SY; Fassati A; Weiss RA
    Cell; 2006 Aug; 126(3):477-87. PubMed ID: 16901782
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1.
    Siebeck N; Hurley DJ; Garcia M; Greene CE; Köstlin RG; Moore PA; Dietrich UM
    Am J Vet Res; 2006 Aug; 67(8):1406-11. PubMed ID: 16881854
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Outcome following surgical removal of nonvisceral soft tissue sarcomas in cats: 42 cases (1992-2000).
    Dillon CJ; Mauldin GN; Baer KE
    J Am Vet Med Assoc; 2005 Dec; 227(12):1955-7. PubMed ID: 16379633
    [TBL] [Abstract][Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.